Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis

Background: Although elevation of HDL-C levels by pharmaceutical drugs have no benefit of cardiovascular endpoint, the effect of high-density lipoprotein/apolipoprotein A1 (HDL/apoA-1) replacement therapy on atherosclerosis is controversial. The current meta-analysis analyzed the effects of HDL/apoA...

Celý popis

Podrobná bibliografie
Hlavní autoři: Ayiguli Abudukeremu, Canxia Huang, Hongwei Li, Runlu Sun, Xiao Liu, Xiaoying Wu, Xiangkun Xie, Jingjing Huang, Jie Zhang, Jinlan Bao, Yuling Zhang
Médium: Článek
Jazyk:English
Vydáno: Frontiers Media S.A. 2021-08-01
Edice:Frontiers in Cardiovascular Medicine
Témata:
On-line přístup:https://www.frontiersin.org/articles/10.3389/fcvm.2021.700233/full

Podobné jednotky